iTRAQ technology combined with LC-TripleTOFMS/MS was applied to identify the DEPs in the three groups, and the target proteins and key pathways were screened for verification, so as to preliminarily explore the mechanism of recuperating from myocardial hypertrophy by treating with ATH-1. The gene discussed is ATOH1; the disease is cardiac hypertrophy.